IL100418A0 - Analogs of acidic fibroblast growth factor having enhanced stability and biological activity - Google Patents
Analogs of acidic fibroblast growth factor having enhanced stability and biological activityInfo
- Publication number
- IL100418A0 IL100418A0 IL100418A IL10041891A IL100418A0 IL 100418 A0 IL100418 A0 IL 100418A0 IL 100418 A IL100418 A IL 100418A IL 10041891 A IL10041891 A IL 10041891A IL 100418 A0 IL100418 A0 IL 100418A0
- Authority
- IL
- Israel
- Prior art keywords
- analogs
- growth factor
- biological activity
- fibroblast growth
- enhanced stability
- Prior art date
Links
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 title 1
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 title 1
- 230000004071 biological effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63245690A | 1990-12-18 | 1990-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL100418A0 true IL100418A0 (en) | 1992-09-06 |
Family
ID=24535601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL100418A IL100418A0 (en) | 1990-12-18 | 1991-12-18 | Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0575339A4 (en) |
| JP (1) | JPH06503962A (en) |
| KR (1) | KR930703439A (en) |
| AU (1) | AU663067B2 (en) |
| CA (1) | CA2098484A1 (en) |
| IE (1) | IE914393A1 (en) |
| IL (1) | IL100418A0 (en) |
| NZ (1) | NZ241021A (en) |
| WO (1) | WO1992011360A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2717495B1 (en) * | 1994-03-18 | 1996-04-12 | Rhone Poulenc Rorer Sa | Recombinant viruses, preparation and use in gene therapy. |
| SK43097A3 (en) * | 1994-10-13 | 1998-10-07 | Amgen Inc | Method for purifying keratinocyte growth factors |
| HUT77746A (en) * | 1994-10-13 | 1998-07-28 | Amgen Inc. | Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| JP2733207B2 (en) * | 1995-05-18 | 1998-03-30 | 工業技術院長 | Pharmaceutical composition containing fibroblast growth factor chimeric protein |
| US6743422B1 (en) | 1996-10-15 | 2004-06-01 | Amgen, Inc. | Keratinocyte growth factor-2 products |
| US7125856B1 (en) | 1999-04-15 | 2006-10-24 | St. Elizabeth's Medical Center Of Boston, Inc. | Angiogenic growth factors for treatment of peripheral neuropathy |
| CA2365434A1 (en) * | 1999-04-15 | 2000-10-26 | St. Elizabeth's Medical Center Of Boston | Angiogenic growth factors for treatment of peripheral neuropathy |
| US20070134204A1 (en) * | 2005-12-09 | 2007-06-14 | Henrich Cheng | Method for treating nerve injury and vector construct for the same |
| US20100286042A1 (en) * | 2007-10-12 | 2010-11-11 | National Institute Of Advanced Industrial Science And Technology | Medicinal Composition Containing Highly Functionalized Chimeric Protein |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62270597A (en) * | 1986-03-07 | 1987-11-24 | プレジデント・アンド・フエロウズ・オブ・ハ−バ−ド・カレジ | Human kind 1 heparin bondable growth factor |
| EP0298723A1 (en) * | 1987-07-07 | 1989-01-11 | California Biotechnology, Inc. | Recombinant fibroblast growth factors |
| NZ226543A (en) * | 1987-10-22 | 1992-02-25 | Merck & Co Inc | Recombinant mutant acidic fibroblast growth factor |
| DE3909009A1 (en) * | 1989-03-18 | 1990-09-20 | Schloemann Siemag Ag | CONTINUOUS CASTING SYSTEM FOR CASTING PROFILES |
-
1991
- 1991-12-17 JP JP4503720A patent/JPH06503962A/en active Pending
- 1991-12-17 AU AU91524/91A patent/AU663067B2/en not_active Ceased
- 1991-12-17 WO PCT/US1991/009441 patent/WO1992011360A1/en not_active Application Discontinuation
- 1991-12-17 IE IE439391A patent/IE914393A1/en not_active Application Discontinuation
- 1991-12-17 NZ NZ241021A patent/NZ241021A/en unknown
- 1991-12-17 CA CA002098484A patent/CA2098484A1/en not_active Abandoned
- 1991-12-18 IL IL100418A patent/IL100418A0/en unknown
-
1992
- 1992-07-17 EP EP92902895A patent/EP0575339A4/en not_active Withdrawn
-
1993
- 1993-06-17 KR KR1019930701853A patent/KR930703439A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0575339A4 (en) | 1995-04-05 |
| KR930703439A (en) | 1993-11-30 |
| NZ241021A (en) | 1993-12-23 |
| JPH06503962A (en) | 1994-05-12 |
| CA2098484A1 (en) | 1992-06-19 |
| WO1992011360A1 (en) | 1992-07-09 |
| IE914393A1 (en) | 1992-07-01 |
| EP0575339A1 (en) | 1993-12-29 |
| AU663067B2 (en) | 1995-09-28 |
| AU9152491A (en) | 1992-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0527781A4 (en) | Methods and formulations for stabilizing fibroblast growth factor | |
| ATA53492A (en) | USE OF CICLOSPORIN FOR PULMONAL ADMINISTRATION | |
| GB8928934D0 (en) | Treatment of birds | |
| ZA919259B (en) | Active fragments of fibroblast growth factor | |
| EP0229750A3 (en) | Human preproinsulin-like growth factor i | |
| EP0476018A4 (en) | Introduction of bacteria in ovo | |
| IL90690A0 (en) | Tissue equivalents and their preparation | |
| EP0554374A4 (en) | Production and use of tracheal antimicrobial peptides | |
| IL83062A (en) | Cloning and expression of acidic fibroblast growth factor | |
| ATE198275T1 (en) | SUBCUTANEOUS IMPLANTS CONSISTING OF NOMGESTROL DERIVATIVES | |
| LV10612A (en) | Saturation of 1-benzyl-3-oxy-methylindazole or its islands and pharmaceutically acceptable basic substances | |
| EP0550035A3 (en) | Composition of stabilized fibroblast growth factor | |
| IL100418A0 (en) | Analogs of acidic fibroblast growth factor having enhanced stability and biological activity | |
| ZA919438B (en) | Use of xanthines for the preparation of a medicament having immuno supressing activity | |
| AU3828195A (en) | Analogs of acidic fibroblast growth factor having enhanced stability and biological activity | |
| IL80302A0 (en) | Biologically active derivatives of human epsilon-interferon | |
| EP0466780A4 (en) | Megakaryocyte growth promoting activity | |
| IL81990A0 (en) | Compounds and pharmaceutical preparations having calcium regulatory activity | |
| EP0522080A4 (en) | High level expression of basic fibroblast growth factor having a homogeneous n-terminus | |
| GB9024895D0 (en) | Therapeutic use of fibroblast growth factor | |
| GB2223496B (en) | Synthetic gene encoding mature human acid fibroblast growth factor | |
| EP0494369A3 (en) | Sterilization of growth factors | |
| IE883495L (en) | Analogs of fibroblast growth factor | |
| ZA875048B (en) | Cloning and expression of acidic fibroblast growth factor | |
| ZA888764B (en) | Analogs of fibroblast growth factor |